Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

SNSE/BIIB stock hub

SNSE/BIIB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SNSE/BIIBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

25.5T

Santiago Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SNSE/BIIB

In the news

Latest news · SNSE/BIIB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.5

P25 n/aP50 n/aP75 n/a

Trailing P/E20

P25 n/aP50 n/aP75 n/a

ROE7.7

P25 n/aP50 n/aP75 n/a

ROIC10.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SNSE/BIIB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

198

Groups with data

Currency

USD

Showing 198 of 198 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	CL
Employees	7,500
Employees Change	-105%
Employees Change Percent	-1.38
Enterprise value	$27.1T
Exchange	Santiago Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	$25.5T
Price	$181
Price currency	USD
Rev Per Employee	1,231,959,352.8x
Sic	2836
Symbol	snse/BIIB
Website	https://www.biogen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.01%
EV Earnings	21.23x
EV/EBIT	11.19x
EV/EBITDA	8.35x
EV/FCF	12.02x
EV/Sales	3.06x
FCF yield	8.85%
Forward P/E	13.49x
P/B ratio	1.47x
P/E ratio	19.96x
P/S ratio	2.76x
PE Ratio10 Y	16.99x
PE Ratio3 Y	19.86x
PE Ratio5 Y	19.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	27.32%
EBITDA Margin	35.38%
FCF margin	24.38%
Gross margin	78.72%
Gross Profit	$7.3T
Gross Profit Growth	2.83%
Gross Profit Growth Q	0.78%
Gross Profit Growth3 Y	-0.4%
Gross Profit Growth5 Y	-6.2%
Net Income	$1.3T
Net Income Growth	-7.26%
Net Income Growth Q	32.85%
Net Income Growth3 Y	-24.05%
Net Income Growth5 Y	-14.55%
Pretax Margin	16.33%
Profit Margin	13.81%
Profit Per Employee	$170.1M
ROA	5.9
Roa5y	6.65
ROCE	10.25
ROE	7.7
Roe5y	13.26
ROIC	10.92
Roic5y	13.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-4.1%
Cagr1y	-26.11%
Cagr3y	-9.59%
Cagr5y	-7.87%
EPS Growth	-8.1
EPS Growth Q	31.1
EPS Growth3 Y	-24.42
EPS Growth5 Y	-13.58
FCF Growth	-0.57%
FCF Growth Q	167.46%
FCF Growth3 Y	19.25%
FCF Growth5 Y	-5.2%
OCF Growth	0.36%
OCF Growth Q	148.94%
OCF Growth10 Y	-4.25%
OCF Growth3 Y	15.58%
OCF Growth5 Y	-6.01%
Revenue Growth	1.23x
Revenue Growth Q	1.93x
Revenue Growth3 Y	-0.55x
Revenue Growth5 Y	-4.64x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.35
Assets	$27.4T
Cash	$4T
Current Assets	$8.2T
Current Liabilities	$2.7T
Debt	$6.1T
Debt EBITDA	$1.8
Debt Equity	$0.35
Debt FCF	$2.71
Equity	$17.3T
Interest Coverage	9.87
Liabilities	$10.1T
Long Term Assets	$19.2T
Long Term Liabilities	$7.4T
Net Cash	$-1.7T
Net Cash By Market Cap	$-6.62
Net Debt EBITDA	$0.52
Net Debt Equity	$0.1
Net Debt FCF	$0.75
Tangible Book Value	$2.9T
Tangible Book Value Per Share	$19,588

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.06
Inventory Turnover	1
Net Working Capital	$1.8T
Quick ratio	2.03
Working Capital	$5.8T
Working Capital Turnover	$2,169

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-34.19%
1Y total return	-26.1%
200-day SMA	159.2
3Y total return	-26.1%
50-day SMA	181.1
50-day SMA vs 200-day SMA	50over200
5Y total return	-33.61%
All Time High	418.5
All Time High Change	-56.74%
All Time High Date	2015-06-22
All Time Low	120.7
All Time Low Change	49.96%
All Time Low Date	2025-05-14
ATR	0
High52	245
High52 Date	2025-06-04
High52ch	-26.1%
Low52	120.7
Low52 Date	2025-05-14
Low52ch	49.96%
Ma50ch	0%
Price vs 200-day SMA	13.73%
RSI	99.96
RSI Monthly	39.24
RSI Weekly	67.74
Sharpe ratio	-0.19x
Sortino ratio	-0.17
Total Return	-1.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$2.5T
Operating Income Growth	4.02
Operating Income Growth Q	-16.14
Operating Income Growth3 Y	-2.11
Operating Income Growth5 Y	-6.25
Operating margin	27.32

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	147,154,881%
Net Borrowing	-264,624,001,000
Shares Insiders	0.2%
Shares Institutions	99.18%
Shares Qo Q	1.16%
Shares Yo Y	1.01%
Short Ratio	3.95

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$2T
Average Volume	0x
Bv Per Share	117,494.3
CAPEX	$-156.1B
Ch10y	-34.19
Ch1y	-26.1
Ch3y	-26.1
Ch5y	-33.61
Ch6m	39.02
Change	0%
Close	181.1
Depreciation Amortization	714,012,419,000
Earnings Date	2026-04-29
EBIT	$2.5T
EBITDA	$3.3T
EPS	$8,643
F Score	6
FCF	$2.3T
FCF EV Yield	8.32x
Financing CF	-300,043,233,000
Fiscal Year End	December
Founded	1,978
Goodwill	5,783,313,423,000
Graham Number	158.64936
Graham Upside	-12.38
Income Tax	$233.5B
Investing CF	-1,425,647,007,000
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	$45.35
Lynch Upside	-74.95
Ma150	168.9
Ma150ch	7.22%
Ma20	181.1
Ma20ch	0%
Net CF	729,327,276,000
Next Earnings Date	2026-07-29
P FCF Ratio	11.3
P OCF Ratio	10.57
Ppne	2,913,805,268,000
Price Date	2026-05-08
Price EBITDA	$7.79
Ptbv Ratio	8.81
Relative Volume	2,000x
Revenue	9,239,695,146,000x
SBC By Revenue	2.96x
Share Based Comp	273,172,302,000
Tax By Revenue	2.53x
Tax Rate	15.47%
Tr6m	39.02%
Z Score	3.12

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SNSE/BIIB pay a dividend?

Capital-return profile for this ticker.

Performance

SNSE/BIIB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SNSE/BIIB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+99.2%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SNSE/BIIB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

100.0

Above 70: short-term overbought

Price vs 200-day MA

+13.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.19

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SNSE/BIIB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current snse/BIIB stock rating?

snse/BIIB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full snse/BIIB analysis?

The full report lives at /stocks/snse/BIIB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for snse/BIIB?

The latest report frames snse/BIIB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the snse/BIIB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.